Former Perlmutter Cancer Center director Benjamin Neel sues NYU over termination

Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel

Alec Kimmelman was named director of the Laura and Isaac Perlmutter Cancer Center, effective immediately.

December 01, 2023

NYU Perlmutter research suggests drug combination could starve pancreatic cancer

A combination of treatments safely decreased growth of pancreatic cancer in mice by preventing cancer cells from scavenging for fuel, a recent study led by researchers at NYU Grossman School of Medicine, its Department of Radiation Oncology, and the Perlmutter Cancer Center found.

October 13, 2023

Vol.49 No.38

In Brief

Michael J. Zelefsky named director of brachytherapy, vice chair for academic and faculty affairs at NYU

Michael J. Zelefsky is joining NYU Langone’s Perlmutter Cancer Center as director of brachytherapy and vice chair for academic and faculty affairs in NYU Grossman School of Medicine’s Department of Radiation Oncology.

September 15, 2023

Vol.49 No.34

In Brief

Nina D’Abreo named chief of the Division of Hematology and Medical Oncology at Perlmutter Cancer Center–Sunset Park

Nina D’Abreo was named chief of the Division of Hematology and Medical Oncology at NYU Langone Health’s Perlmutter Cancer Center–Sunset Park, effective Sept. 1.

September 08, 2023

Vol.49 No.33

In Brief

NYU Langone Health’s Perlmutter Cancer Center opens fourth location in Brooklyn, expands services

NYU Langone’s growing Perlmutter Cancer Center recently opened its fourth location in Brooklyn (Cobble Hill) and is significantly expanding services this year in the borough to provide greater access to cancer services and sub-specialized surgical and medical oncology care for a variety of cancers.

March 31, 2023

Vol.49 No.13

Clinical Roundup

Research reveals why cancers stop responding to kinase-blocking drugs

A study by New York University researchers, published this week in the journal Proceedings of the National Academy of Sciences, explains why cancers not only stop responding to kinase inhibitors but come back stronger, a finding that could inform which drugs oncologists use as a first-line treatment.

February 17, 2023

Vol.49 No.07

Former Perlmutter Cancer Center director Benjamin Neel sues NYU over termination

YOU MAY BE INTERESTED IN

Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel

NYU Perlmutter research suggests drug combination could starve pancreatic cancer

Michael J. Zelefsky named director of brachytherapy, vice chair for academic and faculty affairs at NYU

Nina D’Abreo named chief of the Division of Hematology and Medical Oncology at Perlmutter Cancer Center–Sunset Park

NYU Langone Health’s Perlmutter Cancer Center opens fourth location in Brooklyn, expands services

Research reveals why cancers stop responding to kinase-blocking drugs

Renew today!

Subscriber content

Login